Novartis stock price short-term traders note Novartis stock

Short-term traders note Novartis stock price near $100 as a breakout candidate if broader European pharma stocks rally further. Bollinger Bands indicate narrowing volatility, often preceding a sharp move. Unfortunately, Entresto, one of its top-selling drugs, is facing a patent cliff and will soon experience a significant decline in sales. However, Novartis is ready to take on generics. Despite this patent cliff, it still expects its sales to grow by a high-single-digit percentage for the year, a respectable performance for a pharmaceutical giant. Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks. A steady climb in Novartis stock price to $99.85 reflects renewed investor confidence after Swiss franc weakness boosted export competitiveness. Portfolio managers highlight dividends as a core appeal for long-term holders.